| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6822536 | Schizophrenia Research | 2017 | 6 Pages |
Abstract
TAAR1 is a modulator of monoaminergic pathways and interacts with AKT signaling pathways. Substantial animal model based pharmacological and functional data implying its relevance in SZ are also available. However, this is the first report suggestive of the likely contribution of rare variants in this gene to SZ.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Jibin John, Prachi Kukshal, Triptish Bhatia, K.V. Chowdari, V.L. Nimgaonkar, S.N. Deshpande, B.K. Thelma,